ButcherJoseph & Co. | ESOP Advisors & M&A Advisory

ESOPs in C corps

Despite the unique tax advantage for ESOP-owned S Corporations, companies may prefer to be taxed as a C Corporation for federal income tax purposes. …

Sale to an ESOP compared to other exit strategies

Business owners interested in selling their company are usually aware of the traditionally familiar exit strategies: sell to a strategic buyer, or sel…

ESOPs in S corps

S Corporations are companies that have elected to pass corporate income and losses through to shareholders for federal income tax purposes. …

Properly Structuring and Maintaining an ESOP

Learn more about how to properly structure and maintain an ESOP in this whitepaper….

Defer Long Term Capital Gains Taxes: C-Corp vs. S-Corp [Part 5]

This post discuss how to potentially eliminate capital gains taxes on proceeds from the sale of a business and summary points on a C-Corp vs. S-Corp s…

Defer Long Term Capital Gains Taxes: QRP & Floating Rate Notes [Part 4]

This is the fourth article in a five part series that reviews the Section 1042 Capital Gains Tax Deferral alternative with respect to ESOP structures….

Defer Long Term Capital Gains Taxes: Using a Margin Loan [Part 3]

This post provides an example of how a selling shareholder can use Section 1042 to create liquidity by implementing a margin loan. …

Butcher Joseph Hayes Advises Freedom Pharmaceuticals on Sale to Arseus

In 2013, Freedom Pharmaceuticals expects to achieve turnover of approximately US$ 25 million with an EBITDA margin above the average for the Fagron Gr…